APA

Koyama H., Nishizawa Y., Hosoi M., Fukumoto S., Kogawa K., Shioi A. & Morii H. (19961127). The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2. : Circulation research.

Chicago

Koyama H, Nishizawa Y, Hosoi M, Fukumoto S, Kogawa K, Shioi A and Morii H. 19961127. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2. : Circulation research.

Harvard

Koyama H., Nishizawa Y., Hosoi M., Fukumoto S., Kogawa K., Shioi A. and Morii H. (19961127). The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2. : Circulation research.

MLA

Koyama H, Nishizawa Y, Hosoi M, Fukumoto S, Kogawa K, Shioi A and Morii H. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2. : Circulation research. 19961127.